A factory producing counterfeit medicines in Ghaziabad, Uttar Pradesh was uncovered, where fake Liv-52 tablets were being manufactured and sold with forged documentation.
In a significant crackdown, police in Ghaziabad, Uttar Pradesh have uncovered a factory involved in the manufacturing of counterfeit medications. This operation centered on fake Liv-52 tablets, which were being produced using forged documents, including fake GST numbers and pharmaceutical licenses. The police action resulted in the seizure of thousands of counterfeit tablets, highlighting a serious concern regarding public health and safety due to the circulation of fake drugs.
The operation's revelation raises alarms over the prevalence of counterfeit pharmaceuticals in India, especially considering the growing demand for medicines during the pandemic and beyond. Such illegal activities pose not only a risk to consumers who may unknowingly purchase these drugs believing them to be effective but also undermine the credibility of the healthcare system. The police are currently investigating the full extent of the operation and those involved in it.
This incident highlights the critical need for stringent enforcement against counterfeit drug manufacturing and distribution in India. Authorities are urged to take stronger measures to protect consumers and ensure that only genuine medicines reach the market. Furthermore, this case serves as a reminder of the vulnerabilities within the pharmaceutical supply chain that can endanger public health, necessitating closer scrutiny and regulation to prevent similar occurrences in the future.
